The Nifty Pharma index fell 1.86% to 7,994.30 on profit booking after rising in past three trading sessions.
The index rose 8.11% in three sessions to 8146 on Thursday (5 March 2020), from a recent closing low of 7535.10 recorded on Monday (2 March 2020).
Meanwhile, the Nifty 50 index fell 289.45 points or 2.57% to 10,979.55.
Among the index constituents, Piramal Enterprises (down 8.85%), Wockhardt (down 6.05%), Glenmark Pharmaceuticals (down 3.93%), Aurobindo Pharma (down 3.26%), Lupin (down 2.24%), Cipla (down 2.05%), Sun Pharmaceutical Industries (down 1.2%) and Dr Reddy's Laboratories (down 0.61%) declined.
Strides Shasun (up 1.55%), Alkem Laboratories (up 0.82%), Cadila Healthcare (up 0.78%), GlaxoSmithKline Pharmaceuticals (up 0.75%), IPCA Laboratories (up 0.65%) and Divi's Laboratories (up 0.55%) advanced.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app